H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model

Open Access

Peer-reviewed

Research Article

M. Keith Howard ,

* E-mail: keith_howard@baxter.com

Affiliation Vaccine Research and Development, Baxter BioScience, Orth/Donau, Austria
⨯
Nicolas Sabarth,

Affiliation Vaccine Research and Development, Baxter BioScience, Orth/Donau, Austria
⨯
Helga Savidis-Dacho,

Affiliation Vaccine Research and Development, Baxter BioScience, Orth/Donau, Austria
⨯
Daniel Portsmouth,

Affiliation Vaccine Research and Development, Baxter BioScience, Orth/Donau, Austria
⨯
Otfried Kistner,

Affiliation Vaccine Research and Development, Baxter BioScience, Orth/Donau, Austria
⨯
Thomas R. Kreil,

Affiliation Vaccine Research and Development, Baxter BioScience, Orth/Donau, Austria
⨯
Hartmut J. Ehrlich,

Affiliation Global Research and Development, Baxter BioScience, Vienna, Austria
⨯
P. Noel Barrett

Affiliation Vaccine Research and Development, Baxter BioScience, Orth/Donau, Austria
⨯

Reader Comments (0)

H5N1
Is the Subject Area "H5N1" applicable to this article?

Thanks for your feedback.
Immune serum
Is the Subject Area "Immune serum" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Guinea pigs
Is the Subject Area "Guinea pigs" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Pandemics
Is the Subject Area "Pandemics" applicable to this article?

Thanks for your feedback.